TAT-peptide conjugated repurposing drug against SARS-CoV-2 main protease (3CLpro): Potential therapeutic intervention to combat COVID-19

The Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that originated in Chinese city of Wuhan has caused around 906,092 deaths and 28,040,853 confirmed cases worldwide (https://covid19.who.int/, 11 September 2020). In a life-threatening situation, where there is no specific and licensed...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Mohammad Azam Ansari, Qazi Mohammad Sajid Jamal, Suriya Rehman, Ahmad Almatroudi, Mohammad A. Alzohairy, Mohammad N. Alomary, Takshashila Tripathi, Ali H. Alharbi, Syed Farooq Adil, Mujeeb Khan, M. Shaheer Malik
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2020-11-01
Colecção:Arabian Journal of Chemistry
Assuntos:
SARS-CoV-2
TAT-peptide
3CLpro main protease
COVID-19
In silico
Molecular docking
Acesso em linha:http://www.sciencedirect.com/science/article/pii/S1878535220303713
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados